相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation
Kamil Gotfryd et al.
BMC CANCER (2010)
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Jiahuai Tan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct Mechanisms
Li-Kai Tsai et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Valproate Administered after Traumatic Brain Injury Provides Neuroprotection and Improves Cognitive Function in Rats
Pramod K. Dash et al.
PLOS ONE (2010)
Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice
Anna J. Bowes et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Glycogen synthase kinase 3: more than a namesake
Geetha Vani Rayasam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Differential effects of valproic acid on growth, proliferation and metastasis in HTB5 and HTB9 bladder cancer cell lines
Seok-Soo Byun et al.
CANCER LETTERS (2009)
Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells
S. Lee et al.
CELL PROLIFERATION (2009)
Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Norbert L. Wiech et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?
Eugen Trinka
EPILEPSIA (2009)
Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status
Lorena Travaglini et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Valproic acid enhances protein L-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway
Philippe Cournoyer et al.
NEUROPHARMACOLOGY (2009)
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
Jennifer S. Carew et al.
CANCER LETTERS (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
S. Meloche et al.
ONCOGENE (2007)
Multiple effects of pentyl-4-yn-VPA enantiomers: From toxicity to short-term memory enhancement
Kamil Gotfryd et al.
NEUROPHARMACOLOGY (2007)
Cancer control by phytochemicals
Hoyoku Nishino et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Valproic acid as anti-cancer drug
Martin Michaelis et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Michael K. Rowe et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines
Maria G. Catalano et al.
ENDOCRINE-RELATED CANCER (2007)
Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells
Chien-Lun Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells
M Michaelis et al.
CELL DEATH AND DIFFERENTIATION (2006)
Ras/MAP Kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate
JW Jung et al.
CANCER LETTERS (2005)
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
AJ Kim et al.
JOURNAL OF CELL SCIENCE (2005)
Discriminative power of an assay for automated in vitro screening of teratogens
PS Walmod et al.
TOXICOLOGY IN VITRO (2004)
Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid
M Michaelis et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds
GH Werstuck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
Guang Chen et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons
AC Hall et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Automated in vitro screening of teratogens
PS Walmod et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth
PX Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
